Clinical Research of radiotherapy combined with apatinib mesylate tablets in the treatment of residual, recurrent and metastatic sarcoma

Trial Profile

Clinical Research of radiotherapy combined with apatinib mesylate tablets in the treatment of residual, recurrent and metastatic sarcoma

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 20 Nov 2017

At a glance

  • Drugs Rivoceranib
  • Indications Sarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Nov 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top